1. Home
  2. DARE vs SWIN Comparison

DARE vs SWIN Comparison

Compare DARE & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • SWIN
  • Stock Information
  • Founded
  • DARE 2015
  • SWIN 2017
  • Country
  • DARE United States
  • SWIN Hong Kong
  • Employees
  • DARE N/A
  • SWIN N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • SWIN
  • Sector
  • DARE Health Care
  • SWIN
  • Exchange
  • DARE Nasdaq
  • SWIN Nasdaq
  • Market Cap
  • DARE 26.3M
  • SWIN 32.1M
  • IPO Year
  • DARE N/A
  • SWIN 2023
  • Fundamental
  • Price
  • DARE $2.52
  • SWIN $3.29
  • Analyst Decision
  • DARE Strong Buy
  • SWIN
  • Analyst Count
  • DARE 3
  • SWIN 0
  • Target Price
  • DARE $12.50
  • SWIN N/A
  • AVG Volume (30 Days)
  • DARE 443.5K
  • SWIN 272.7K
  • Earning Date
  • DARE 08-11-2025
  • SWIN 08-21-2025
  • Dividend Yield
  • DARE N/A
  • SWIN N/A
  • EPS Growth
  • DARE N/A
  • SWIN N/A
  • EPS
  • DARE N/A
  • SWIN N/A
  • Revenue
  • DARE $25,909.00
  • SWIN $3,316,000.00
  • Revenue This Year
  • DARE $99,756.91
  • SWIN $29.79
  • Revenue Next Year
  • DARE $119.77
  • SWIN $54.60
  • P/E Ratio
  • DARE N/A
  • SWIN N/A
  • Revenue Growth
  • DARE N/A
  • SWIN N/A
  • 52 Week Low
  • DARE $2.11
  • SWIN $1.16
  • 52 Week High
  • DARE $4.60
  • SWIN $4.40
  • Technical
  • Relative Strength Index (RSI)
  • DARE 41.75
  • SWIN 58.50
  • Support Level
  • DARE $2.37
  • SWIN $2.88
  • Resistance Level
  • DARE $2.54
  • SWIN $4.40
  • Average True Range (ATR)
  • DARE 0.14
  • SWIN 0.48
  • MACD
  • DARE -0.00
  • SWIN 0.01
  • Stochastic Oscillator
  • DARE 59.56
  • SWIN 47.14

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About SWIN Solowin Holdings

Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.

Share on Social Networks: